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INTRODUCTION 
 Most of the surgeries within the orbit can be performed under  
regional anaesthesia.  Cataract surgery is  routinely carried  out  under 
regional anaesthesia in our institution. 
 Regional anaesthesia for ophthalmic surgery may be administered 
by anaesthesiologist, provided they receive appropriate training in 
performing the technique and are fully conversant with the associated 
risks and complications and can treat them accordingly. Regional 
anaesthesia¹ is a better alternative, whenever general anesthesia is 
undesireable or contraindicated. 
 Retrobulbar and peribulbar blocks 1,2,3 provide adequate 
anaesthesia for surgery on the  cornea, anterior chamber and lens. 
Concern over complications associated with retrobulbar block and need 
for an accessory block of the facial nerve to prevent activity of  the 
orbicularis oculi muscle led  to  the  pursuit of peribulbar block  technique 
in  ophthalmic anaesthesia. 2,3,4 
Peribulbar block is considered preferable over retrobulbarblock in  
achieving anesthesia for intraocular and extraocular surgeries. Peribulbar 
  
 
block is widely used, because it is easier to perform and less painful. Has 
a higher margin of safety and equally effective without the need for 
accessory facial nerve block. Local anesthetic solution is deposited within 
the orbit but outside the muscle cone. Kelman was first known to have 
performed this technique  in 1970. In 1985, Davis & Mandel 5,6 reported 
the use of peribulbar block. Davis & Mandel reviewed  16,225 peribulbar 
blocks and found them to be effective with a very low complication rate.  
 In our study, we compare the efficacy of peribulbar block in 
cataract surgery  using  the   combination  of  1:1  mixture of 2% 
lidocaine  with 0.5% bupivacaine  and   1:1  mixture  of  2% lidocaine   
with   0.75% ropivacaine  regarding the  time required for onset of 
surgical anaesthesia and quality of postoperative analgesia. 
 
 
 
  
 
 
 
 
AIM OF THE STUDY 
 
To evaluate the efficacy of peribulbar block with  the combination 
of 2% Lidocaine and 0.75%  Ropivacaine in comparison with 2% 
Lidocaine  and  0.5%  Bupivacaine  for cataract surgery . 
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VERTICAL SECTION OF THE RIGHT EYE 
  
 
 
ANATOMY AND NERVE SUPPLY OF THE EYEBALL 
THE ORBIT   
It is 40 -50 mm deep and pyramidal in shape with its base at the 
orbital opening and its apex pointing to the optic foramen. Its volume is 
approximately 30ml, which about 7 ml is occupied by the globe and its 
muscle cone, and the remainder by  loose connective tissue through 
which local anaesthetic solutions can spread. The lateral walls of both 
orbits form an angle of 90˚ to each other and the angle between the 
medial and lateral wall of each orbit is  45˚. The medial wall is parallel to 
the sagittal plane. 
THE GLOBE  
The eyeball is situated in the anterior part of the orbital cavity 
closer to the roof than the floor and nearer the lateral than the medial 
wall. This relationship is important when considering needle access , 
which is usually either medially or inferolaterally where the gap between 
globe and orbital wall is greatest. 
 
 
  
 
 
 
 
 
SUPEROLATERAL ASPECT OF THE RIGHT EYE. 
Extraocular muscles 
  
 
SCLERA  
It forms the fibrous layer of the eyeball. It is about 1 mm thick in 
the adult. The sclera is relatively tough, but is easily pierced by needles. 
Deep to  the sclera  is the uveal tract, which comprises the ciliary body , 
iris and choroid layer. Superficial to, and enclosing the sclera  is the 
membranous Tenon’s capsule, lying directly underneath the conjunctiva.  
EXTRAOCULAR MUSCLES: 
The four recti and two oblique muscles control eye movement and 
influence intra ocular pressure. The lateral rectus is innervated by the 
abducent  nerve [ VI cranial nerve ] , the superior oblique  by the 
trochlear nerve    [IV cranial nerve]   and   the   rest by   the oculomotor    
nerve    [III cranial nerve ].  Nerves enter the muscles on their intraconal 
surface, with the exception of the superior oblique. The cranial nerves 
enter the cone and pierce the muscles on their intraconal surface. 
The sensory supply is through the branches of the trigeminal [ V 
cranial nerve ]  nerve. The first division of the trigeminal nerve 
[ophthalmic nerve ] enters the orbit via the superior orbital fissure and 
supplies branches intraconally to the sclera and cornea.  After leaving the 
orbit via the superior orbital notch it supplies to the upper lid and 
conjunctiva     extraconally.    The    second   division   of   the  trigeminal  
  
 
Nerve supply of the eye (lateral view) 
 
 
 
 
 
  
 
[maxillary nerve] enters the orbit via the inferior orbital fissure. Branches 
of this nerve are entirely extraconal and supply the lower lid and inferior 
conjunctiva after leaving the orbit via the inferior orbital foramen. 
The Ciliary Ganglion 
It is a small quadrilateral body about the size of pin's head situated 
between the optic nerve & lateral rectus near the apex of the orbit. It has 3 
roots: 
1) Sensory root arises from naso-ciliary nerve. The fibres do not relay 
 in the ciliary ganglion 
2)  Parasympathetic root comes from 3rd cranial nerve. The fibers 
 relay in the ganglion. 
3)  Sympathetic root  arises from the sympathetic plexuses around the 
internal carotid artery. They are post-ganglionic fibers, and pass 
through  the ganglion without further relay. The ciliary ganglion 
gives 6 - 10 short ciliary nerves which contain the 3 types of 
innervation. 
  
 
 
PERIBULBAR BLOCK 
There are various techniques to administer a peribulbar block. 
Single injection technique provides 7,9,10  adequate anaesthesia, although 
akinesia is not  guaranteed. The most commonly used single injection 
technique is an  inferolateral injection. In ophthalmic practice, complete 
akinesia is seldom required.  
Two-site injection technique involving inferotemporal and 
superonasal sites  achieves complete akinesia of the eyeball. The 
anaesthetsiologist should explain the   anaesthetic technique to the patient  
in clear, vernacular language, with appropriate reassurance. All 
monitoring and  anaesthetic  equipments  in both the anaesthetic room 
and operating room should be  checked. All drugs and equipments for 
resuscitation  should   be       readily available. Consent of the patient to 
surgery and anaesthesia should be obtained and verified.   
 The axial length of the eye should be confirmed by ultrasound 
scan. Intravenous access with an indwelling canula should be established 
before performing the block. ECG, non invasive blood pressure & oxygen 
saturation of the patients are monitored. 
 
  
 
 
PERIBULBAR BLOCK 
PERIBULBAR BLOCK–Inferotemporal injection 
 
 
 
 
 
 
 
 
 
 
PERIBULBAR BLOCK – Superonasal injection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
  
 
 
 
Peribulbar block using two injection technique : 6,8,9,10 
• Both the upper and lower eye  lids  were cleaned with 5% solution 
of Povidone Iodine swab.  
• The patient is placed in supine position and asked to look  straight.  
• A 10 ml syringe with a 22 gauge, 25 mm needle is used to perform 
the block 
The needle is inserted in the inferotemporal region through the 
skin, at the junction of medial 2/3rd and lateral 1/3rd of the lower orbital 
margin. Once the needle is under the globe, it is directed along the orbital 
floor  up  to the  depth of the mid-orbit in the lateral extra conal space and 
not in an upward and inward direction to avoid injury to optic nerve. 
After careful negative aspiration, 5 ml of local anesthetic is given. 
  The second injection 11 was given in the superonasal area by 
inserting the same needle through the upper eyelid vertically above the 
medial limbus to a depth of 2cm, aiming tangentially away from the 
globe in the medial extra conal space and 3 ml of local anesthetic is 
given. Addition of hyaluronidase   improves penetration of the local 
anesthetic drugs.  
  
 
Fullness of the upper lid indicates an increase in the orbital volume 
and correct site of injection. Intermittent ocular compression is applied 
after the injection for 10 – 20 Minutes. 
COMPLICATIONS OF PERIBULBAR BLOCK: 
Chemosis 
This is normally disappears completely in few minutes with the 
application of orbital compression. 
Central retinal artery occlusion12  
This can result from a retrobulbar hemorrhage and may result in 
total loss of vision, if not treated. If retrobulbar hemorrhage occurs, the 
patient's intraocular pressure and central retinal artery pulsations should 
be monitored. If external pressure on the globe is high enough to result in 
compression of the retinal arteries, then the surgeon should perform a 
deep lateral canthotomy or an anterior chamber paracentesis to 
decompress the orbit.  
Globe perforation13 
Globe perforation is diagnosed by sudden pain on  injection,  loss 
of vision, poor red reflex  or vitreous haemorrage. There is a serious risk 
  
 
of retinal haemorrage  and detachment which may require laser 
retinopexy or vitrectomy. 
Inadvertent brain stem anesthesia14  
Accidental injection into the CSF can occur during the block due to 
perforation of the meningeal sheaths that surround the optic nerve. The 
patient may experience disorientation, amaurosis fugax, aphasia, 
hemiplegia, unconsciousness, convulsions, and respiratory or cardiac 
arrest  a few minutes after the injection. Direct intravascular injection via 
the optic nerve sheath or local anesthesia carried by the ophthalmic and 
internal carotid artery by retrograde flow to the thalamus and midbrain 
can also present the same way. This situation requires prompt recognition 
and treatment (including airway control, respiratory support, possible 
cardiac intervention, etc.). Hence a patient should never be left 
unattended after the block.  
Advantages of peribulbar block over retrobulbar block 
1. Less chances of retrobulbar haemorrhage.   
2.  Lower incidence of perforation of eye or injury to the optic nerve. 
3.  The potential for intraocular or intradural injection is decreased, 
because the local anesthetic is deposited outside the muscle cone. 
  
 
Disadvantages of peribulbar block 
1.  Akinesia of the extra-ocular muscles may be less complete. 
2.  Slower onset. 
3.  Greater volume of local anaesthetic required. 
4.  Greater incidence of periorbital ecchymosis & conjunctival 
 chemosis. 
Contraindications to peribulbar block 
• Axial length >26mm: In severely myopic patients, the globe often 
 has a long diameter. This increases the likelihood of  globe 
 perforation due to increased  globe length and thinner sclera. 
• Perforated eye or an open eye injury: The pressure from injecting 
fluid  behind the eye may cause extrusion of intraocular contents 
through the wound. 
• Infected eye. 
• Patients with cardiovascular instability, COPD and 
skeletomuscular disorders (eg :rheumatoid arthritis and osteo 
arthritis) may be unable to lie flat and still. 
• Patients taking  anticoagulants:  The dose should be adjusted to 
reduce the INR to  <2.0. 
  
 
PHARMACOLOGY OF LOCAL ANAESTHETIC  
DRUGS 
Local anaesthetics are drugs which cause reversible loss of sensory 
perception, motor and autonomic blockade, in a restricted area of the 
body without causing any structural damage to neurons. 
STRUCTURE OF LOCAL ANAESTHETIC DRUGS 
Local aneasthetic drug consists of a hydrobhobic,15 aromatic ring 
and a hydrophilic tertiary amine linked together by an intermediate bond, 
which is either an aminoamide or aminoester. The tertiary amine is a 
base, which is partially protonated, having some positive charge at 
physiologic pH. 
CLASSIFICATION  
Local anaesthetic drugs may be classified based on either its 
chemistry or potency and duration of action.  
  
 
 
MODE OF ACTION 
Hydrophilic local aneasthetic bases are poorly to sparingly soluble 
in water but are relatively soluble in organic solvents. Thus, most local 
aneasthetic drugs are available as hydrochloride salts.  
          At physiological pH, the local aneasthetic molecule is partially 
ionized. The equilibrium between the unionized base form[B] and the 
ionized cationic form [BH+] depends on the pKa  of the local aneasthetic 
drugs. Only  the unionized base form can penetrate the nerve fibre. Once 
inside the neuron; it gets reionized and acts on the Na+ channel from the 
inner side of the nerve fibre. 
          Local anaesthetic drugs block nerve conduction by decreasing the 
entry of Na+ ions during an action potential. The rate of rise of action 
potential and maximum depolarization decreases. Local depolarization 
falls to reach the threshold potential and conduction block results.  
 
 
 
 
 
 
  
 
 
FACTORS AFFECTING CLINICAL PHARMACOLOGY OF 
LOCAL  ANAESTHETIC AGENTS  
Anaesthetic Potency 
Hydrophobicity is the most important factor in determining 
anaesthetic potency. Drugs which are more hydrophobic are most potent 
and long acting than their less hydrophobic congeners.16   
Onset Of Action 
             Drugs having their pKa close to the  physiologic pH of 7.4 are 
faster acting, because a relatively higher percentage of drug is in the  
undissociated base form and it is this form which penetrates the axon.  
The addition of bicarbonate to local anaesthetic solution accelerates 
the onset  of block. Higher pH of the solution increases the amount of 
drug in unchanged base form, which enhances the rate of diffusion across 
the nerve sheath, resulting in more rapid onset.  
Duration of action 
         Duration of anaesthesia is markedly influenced by peripheral 
vascular effects of local anaesthetic agents. Most drugs have a biphasic 
effect on vascular smooth muscle. At low concentrations they tend to 
  
 
cause vasoconstriction, whereas at higher, clinically administered 
concentrations, they cause vasodilatation. 
         Addition of vasoconstrictor like adrenaline [1 in 200,000] prolongs 
the duration of action and reduces systemic toxicity by decreasing their 
rate of removal from the injection site. 
Differential Blockade17,18 
         Local anaesthetic drugs, when used in lower concentration 
selectively block sensory fibres without causing motor blockade. The 
sensitivity is determined by diameter of fibres and fibre type. In general, 
smaller  and non myelinated fibres are blocked more easily than larger C 
and myelinated fibres. 
PHARMACOKINETICS: 19,20 
Absorption 
        The systemic absorption of drugs from the site of injection depends 
on the dose and volume of drugs, addition of vasoconstrictors, site of 
injection [absorption highest after intercostal block and least after 
subcutaneous injection] and individual characteristics like protein binding 
of local anaesthetic drugs. Amide local anaesthetic drugs are bound to  α1 
acid glycoprotein in plasma, whereas Ester local anaesthetic drugs have 
negligible protein binding activity.    
  
 
Biotransformation and excretion  
         The aminoesters are hydrolysed in plasma by pseudocholinesterase 
enzymes, whereas, aminoamides are degraded in the liver microsomes by 
dealkylation and hydrolysis  and the metabolites are excreted through the 
kidneys. 
SYSTEMIC TOXICITY AND ADVERSE EFFECTS:  
Cardio vascular system toxicity  
Local anaesthetic drugs depresses myocardial automaticity and 
reduce duration of refractory period. At higher concentrations myocardial 
contractility and condution velocity are depressed. These effects are due 
to cardiac sodium channel blockade. Excessive dosage or accidental 
intravascular injection can cause bradycardia, heart block, hypotension, 
arrhythmias, circulatory collapse and cardiac arrest. Bupivacaine may 
induces severe cardiac arrhythmias   including ventricular fibrillation in 
various animal species. These electrophysiologic effects of bupivacaine 
may result in conduction abnormalities, leading to reentrant type of 
arrhythmias. This is more common with bupivacaine and less with 
ropivacaine. 
  
 
Central nervous system toxicity 
          Initial symptoms of CNS toxicity are circumoral numbness, tongue 
paresthesia, dizziness, disorientation, drowsiness, tinnitus and visual 
disturbances. Objective signs are initially excitatory in nature and include 
restlessness, tremors, twitching of muscles followed by convulsions, 
respiratory depression and death.  
Local tissue toxicity 
       Use of vasoconstrictors enhance local tissue damage. Hence 
vasoconstrictors should not be used for digital blocks, pinna and penile 
block. Among local anaesthetics, bupivacaine has the highest local tissue 
toxicity. 
Hypersensitivity reactions 
Para amino benzoic acid, a metabolite of ester linked local 
anaesthetic drugs have been associated with allergic reaction like rashes, 
bronchial asthma and hypotension. Hypersensitivity reactions are rare 
with amide local anaesthetics. It may be due to methylparaben, which is 
used in commercial preparations of  local anaesthetic solutions as a 
stabilizing agent. 
 
[ 
  
 
 
PHARMACOLOGY OF BUPIVACAINE 
 
Bupivacaine  is an amide local  anaesthetic, systhesized by 
A.F.Ekenstam in 1957 and brought into clinical use in 1963. 
Structure  of  bupivacaine 21 
Formal chemical name (IUPAC) 
1-butyl-N-(2,6-dimethylphenyl) piperidine-2-carboxamide 
Chemical formula:   C18H28N2O·HCl·H2O 
 It is produced for clinical use as a racemic mixture, containing 
equal proportion of the “S” and “R” enantiomers and  supplied as  
hydrochloride salt. 
 
 
 
 
 
 
  
 
STRUCTURE OF BUPIVACAINE 
 
 
 
 
 
 
 
3DIMENSIONAL STRUCTURE OF BUPIVACAINE 
 
 
 
 
  
 
 
Physicochemical profile 
Molecular weight (base) 288 
pKa 8.1 
Octanol / Water partition coefficient High 
Lipid solubility 28 
Plasma protein binding 95% 
 
Pharmacodynamics 
The clinical profile of nerve blockade produced by bupivacaine 
differs from  that of lidocaine. The onset of action is slower and the 
duration of action is considerably longer. The sensory block produced by 
bupivacaine tends to be more marked than the motor block.   
 
 
 
  
 
 
Pharmacokinetics 
Bupivacaine is rapidly absorbed from the site of injection. The rate 
of  rise in plasma bupivacaine concentration and the peak plasma 
concentration  obtained depend on the route of administration. There is 
also some inter- individual variation and peak systemic concentration  
occurs between 5 and 30 minutes after administration. The addition of a 
vasoconstrictor delays  absorption and result in lower plasma 
concentration of bupivacaine. 
Pharmacokinetic Profile 
Volume of distribution 73 litres 
Clearance 0.47 l/min 
t ½ α 2.7 min 
t ½β 28 min 
t ½γ 3.5 hrs 
 
  
 
Metabolism 
 Possible pathways for metabolism of bupivacaine include aromatic  
hydroxylation, N-dealkylation, amide hydrolysis and conjugation. Only 
the N-dealkylated metabolite, N-desmethylbupivacaine has been 
measured in blood and urine after epidural and spinal administration. The 
degradation of  bupivacaine takes place in the liver. Renal disease is 
unlikely to alter  the  kinetics of bupivacaine to any great extent. Less 
than 10% of the drug is excreted unchanged in urine.  
 The onset of action of bupivacaine occurs 20 -30 minutes after a 
peripheral nerve block and duration lasts for 8-9 hours. 
Clinical Applications 
• Infiltration anaesthesia 
• Peripheral nerve blocks 
• Central neuraxial blocks (intrathecal,epidural and caudal) 
  
 
Preparations Available 
 0.5%  bupivacaine solution in 20 ml vial with sodium chloride 8mg 
and methylparaben 1mg as preservative. 
 5mg/ml (0.5%) bupivacaine and 80 mg dextrose in 4 ml ampoules 
for  intrathecal injection 
Systemic toxicity 
  The ratio of the dosage required for irreversible cardiovascular 
collapse [CC] and the dosage that will produce CNS toxicity [CC /CNS 
ratio]  is lower for bupivacaine  than lidocaine. 
The CC/CNS dose ratio for bupivacaine 3.7 ±  0.5. 
Blood level ratio of   CC/CNS  for bupivacaine 1.6 ± 0.1. 
Recommended Safe Dose: 2mg/kg 
Toxic plasma concentration: >1.5 micro gram/ml. 
Maximum single dose for infiltration in adults : 175mg. 
 
 
  
 
 
PHARMACOLOGY OF ROPIVACAINE 
 
Ropivacaine  is a new aminoamide local anaesthetic. It is one of 
the group of local anaesthetic drugs, the  pipecoloxylidides,  which was  
brought into clinical use in 1992 .It is a single “S” enantiomer. It has an 
enantiometric purity of 99.5%.  
Structure of Ropivacaine22 
Formal Chemical Name (IUPAC) 
 (S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide 
 Chemical formula: C17H26N2O2.HCl.H2O  
Physicochemical profile 
Molecular weight (base) 274 
pKa  (25˚C) 8.1 
Octanol / Water partition 
coefficient 
2.9 
Lipid solubility 6.1 
Plasma protein binding 94% 
 
  
 
STRUCTURE OF ROPIVACAINE 
 
 
 
 
 
3 DIMENSIONAL STRUCTURE OF ROPIVACAINE 
 
 
 
  
 
 
 
Pharmacokinetics 23 
     Ropivacaine is 2-3 times less lipid soluble and has a smaller 
volume of  distribution, greater clearance, and shorter elimination  
half-life than  bupivacaine in humans. The two drugs have a similar  
pKa and plasma protein binding. Ropivacaine undergoes hepatic 
biotransformation and only a minor proportion is excreted unchanged in 
urine.  
Pharmacokinetic Profile 
Volume of distribution 59±7 litres 
Clearance 0.82±0.16 l /min 
Elimination half life 111± 62 min. 
 
Metabolism 
 It is rapidly cleared from plasma and it is extensively metabolished 
by  cytochrome P450 to 2’,6’-pipecoloxylidide[PPX], 3’-OH  ropivacaine 
and 4’-OH ropivacaine. 
  
 
 
Clinical Applications 24 
• Infiltration anaesthesia 
• Peripheral nerve blocks 
• Central neuraxial blocks (intrathecal, epidural and caudal)   
ADVANTAGES OF ROPIVACAINE OVER EXISTING LOCAL ANAESTHETIC AGENTS 
The stereospecificity of s-ropivacaine decreases cardiotoxicity 25 
The bupivacaine and ropivacaine molecules both have chiral 
centers. Commercial bupivacaine is a 50:50 racemic mixture of the S- and 
R- enantiomers. Because of its greater affinity and dwell time at voltage-
gated  sodium channels, the R configuration confers greater cardiotoxicity 
to racemic  bupivacaine. Compared to the S-enantiomer, R-bupivacaine 
binds three times  more firmly to the sodium channel, and unbinds 4.4 
times as slowly. R- bupivacaine is also more arrhythmogenic, and slows 
ventricular conduction 4.6  times as much as S-bupivacaine. Ropivacaine 
is manufactured as the pure S- enantiomer in order to take advantage of 
the decreased cardiotoxicity of the S- configuration.  
  
 
Ropivacaine has a smaller direct negative inotropic and 
arrhythmogenic effect compared with   bupivacaine.      A study which 
measured the effect of bupivacaine and ropivacaine on multiple 
electrophysiologic parameters in isolated Purkinje fiber-ventricular 
muscle preparations found that bupivacaine produced greater depression 
of cardiac excitability and conduction.  
Equivalent myocardial depression with ropivacaine was produced 
at concentrations twice that of bupivacaine. In addition, bupivacaine 
induced electrophysiological alterations which could make re-entrant type 
ventricular arrhythmias more likely. These findings were consistent with 
another study that examined the effect of ropivacaine and bupivacaine on 
isolated rabbit hearts. Similar myocardial depression with ropivacaine 
was produced at concentrations twice as great as bupivacine.  
Bupivacaine produced more severe arrhythmias (AV block and 
ventricular arrhythmias) and more rapid onset of myocardial depression. 
In a live pig model in which local anesthetics were directly infused into 
the left anterior descending coronary artery, the electrophysiologic 
toxicity ratio of bupivacaine to ropivacaine (determined by the dose of 
drug required to produce prolongation of the QRS interval) was 6.7 : 15. 
These studies suggest that the direct myocardial toxicity of ropivacaine is 
about half that of bupivacaine. 
  
 
Reduced CNS  Toxicity25 
Ropivacaine produces mild CNS effects (lightheadedness, tinnitus,  
tongue numbness) and is less likely to cause convulsions than 
bupivacaine. If convulsions occur, they are of shorter duration than 
produced by bupivacaine and resuscitation is almost always effective if 
started immediately This is not always seen with bupivacaine overdosage  
Preparations  available  
1%  Ropivacaine in 10 ml ampoule 
0.75% Ropivacaine in 4, 10 and 20 ml ampoules. 
0.5% Ropivacaine in 10 ml and 20 ml ampoule 
Recommended Safe Dose: 3.5mg/kg   
Toxic plasma concentration: >4 micro gram/ml. 
Maximum single dose for infiltration in adults : 225mg. 
  
 
 
PHARMACOLOGY OF LIDOCAINE 
 
Lidocaine, the first amino amide-type local anesthetic, was first 
synthesized under the name Xylocaine by Swedish chemist Nils Löfgren 
in 1943. His colleague Bengt Lundqvist performed the first injection, 
experimenting on himself. It was first marketed in 1949. Lidocaine also 
has antiarrhythmic properties.  
Structure of Lidocaine19 
Formal Chemical Name (IUPAC) 
2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide   
Chemical formula: C14H22N2O 
Physicochemical profile  
Molecular weight (base) 234 
pKa  (25˚C) 7.9 
Octanol / Water partition coefficient Low 
Lipid solubility 2.9 
Plasma protein binding 64%   
 
  
 
STRUCTURE OF LIDOCAINE 
 
 
 
3 DIMENSIONAL STRUCTURE OF LIDOCAINE 
 
  
 
Pharmacokinetics 
Lidocaine is approximately 95% metabolized (dealkylated) in the 
liver by CYP3A4 to the pharmacologically-active metabolites mono ethyl 
glycine xylidide [MEGX]  and then subsequently to the inactive glycine 
xylidide. MEGX has a longer half life than lidocaine but also is a less 
potent sodium channel blocker.  
The elimination half-life of lidocaine is approximately 90–120 
minutes. 
Pharmacokinetic Profile 
Volume of distribution 91 litres 
Clearance 0.95 1/min 
t ½ α 1.0min 
t ½ β 9.6 min 
t  ½γ 1.6 hrs 
 
Clinical Applications 
• Infiltration anaesthesia 
• Peripheral nerve blocks 
• Central neuraxial blocks (intrathecal, epidural and caudal) 
• Topical anaesthesia  
• Intravenous regional anaesthesia  
  
 
Indications 
Lidocaine, when compared to bupivacaine, has a quicker onset of 
action  and  shorter  duration  of  action.  Lidocaine  is  also  a                 
Class 1B antiarrhythmic drug, used intravenously for the                       
treatment of ventricular arrhythmias. 
Preparations available  
2% lidocaine (plain) - 30 ml vial – 2%lidocaine 20mg and sodium 
methylparaben 0.1% each ml. 
2% lidocaine with adrenaline ( adrenaline 1 in 2 lakhs ) - 30ml 
vials. 
5% lidocaine heavy  (2ml ampoules ) for spinal anaesthesia. 
2% lidocaine without preservative (50ml vial)  for intravenous use. 
Recommended Safe Dose :  3 mg/kg   without  adrenaline. 
 7 mg/kg   with   adrenaline. 
Toxic plasma concentration: >5 micro gram/ml. 
Maximum single dose for infiltration in adults : 300mg without 
adrenaline. 
 
  
 
 
REVIEW OF LITERATURE.  
 
Luigi Gioia, MD*, Edi Prandi, MD*, Marco Codenotti, MD†, 
Andrea Casati, MD*, Guido Fanelli, MD*, Tiziana Monica Torri, BS*, 
Claudio Azzolini, MD†, and Giorgio Torri, MD 26  et al compared  
peribulbar anesthesia with either 0.75% ropivacaine or  2% lidocaine and 
0.5% bupivacaine mixture for vitreoretinal surgery. They demonstated 
that 0.75% ropivacaine has an onset similar to that of the 2% lidocaine 
and 0.5% bupivacaine mixture and provides a better quality of post 
operative analgesia. 
Huha T, Ala-Kokko TI, Salomaki T, Alahuhta S 27 et al  compared 
the  clinical efficacy and pharmacokinetics of 1% ropivacaine and 0.75% 
bupivacaine in peribulbar anaesthesia for cataract surgery. They 
compared akinesia of the globe after injection of the local anaesthetic.  
Lid akinesia was significantly more complete in the ropivacaine group. 
There were no differences between the groups with respect to peri-
operative analgesia or duration of akinesia. They demonstrated no 
clinically significant differences in the quality of the sensory and motor 
block between 1% ropivacaine and 0.75% bupivacaine when used for 
peribulbar anaesthesia. 
  
 
Perello A, George J, Skelton V, Pateman J 28 et al compared  
ropivacaine 0.5% , bupivacaine 0.375% - lidocaine 1% and ropivacaine 
0.5% - lidocaine 1% mixtures for cataract surgery. They concluded that 
there was a slower onset of akinesia in using ropivacaine alone.  
D. K. Woodward, A. T. S. Leung, 29 et al studied  peribulbar 
anaesthesia with 1% ropivacaine and hyaluronidase 300 IU ml–1. In 
comparison with 0.5%bupivacaine,2% lidocaine and hyaluronidase 
50 IU ml–1  . They showed no difference in the rate of onset and degree of 
akinesia achieved. 
Gillart T, Barrau P, Bazin JE, Roche G, Chiambaretta F, Schoeffler 
P 30 et al study was compared the effects of ropivacaine and bupivacaine, 
each combined with lidocaine, during peribulbar anesthesia by single 
medial injection for cataract surgery. They concluded that  lidocaine with 
ropivacaine produces better anaesthesia and similar analgesia when 
compared to   lidocaine with bupivacaine. 
Mehmet Borazan, Aylin Karalezli, Sibel Oto, Cengiz Algan and 
Yonca Aydin Akova 31 et al  compared   bupivacaine 0.5% and lidocaine 
2% mixture with levobupivacaine 0.75% and ropivacaine 1% in 
peribulbar anaesthesia for cataract surgery with phacoemulsification.  
  
 
They concluded there was no significant difference between the groups  
regarding duration of sensory and  motor blockade and surgical analgesia. 
Nociti JR, Serzedo PS, Zuccolotto EB, Cagnolati CA, Nunes AM 
32et al  compared 1%  ropivacaine with 0.75% bupivacaine in peribulbar 
block and noted that there was a faster onset of peibulbar block with 
ropivacaine.  
Luchetti M, Magni G, Marraro G33 et al conducted a prospective, 
randomized, double- blinded study of ropivacaine 0.75% versus 
bupivacaine 0.5% and mepivacaine 2% for peribulbar anesthesia.  
Corke PJ, Baker J, Cammack R,34 et al  compared  1% ropivacaine 
and mixture of 2% lignocaine and 0.5% bupivacaine for peribulbar 
anaesthesia in cataract surgery. They concluded that both  the groups had 
excellent surgical analgesia and akinesia  
Didonato A 35et al  compared efficacy of 0.5% levobupivacaine 
with 0.75% ropivacaine for peribulbar anaesthesia in cataract surgery. 
0.5% levobupivacaine showed early onset of sensory and motor blockade 
and better akinesia score than 0.75 % ropivacaine. 
Olmez cakmak 36et al compared the effects of 0.75%  ropivacaine 
with those of 2% lidocaine  on quality of the blockade in peribulbar block 
  
 
for cataract surgery. They concluded that  duration of  the motor block 
obtained with  ropivacaine was longer. 
L. Trivedi, H. Trivedi, D. Tripathi, P. Jha, K. Bhalani & P. Raval 37 
et al conducted a study to evaluate the efficacy of ropivacaine 0.75% with 
hyaluronidase 50 IU/ml and to compare the quality of block with 
bupivacaine 0.5% with hyaluronidase 50 IU/ml They demonstrated 
ropivacaine has better hemodynamic profile with greater reduction in IOP 
as compared to bupivacaine. 
Jetzy Jaworski 38et al studied 1% ropivacaine versus 2% lidocaine 
with  0.5% bupivacaine  and 2% lidocaine with  1% ropivacaine. They 
concluded that the  onset of akinesia and post operative pain relief were 
similar in all groups.  
 
 
 
  
 
 
MATERIALS AND METHODS 
 
This is a prospective, randomized, double blinded study conducted 
between July and September 2010, at Chengalpattu Medical College  
Hospital,  after getting approval from the ethical committee.  
Our study group had a total of 60 patients who underwent small 
incision cataract surgery during this period.  
An anaesthesia consultant randomized the patient groups on the 
day of surgery from the ophthalmic list into group R and group B by draw 
of lots. The same anaesthesia consultant also drew up 8ml of either 
control or study drug using sterile precautions and coded them. 
An anaesthsia resident who was blinded to this study was given the 
coded syringes by the anaesthsia consultant and was asked to perform the 
peribulbar block. 
Another resident  [myself]  collected the data as per proforma. 
  
 
Inclusion criteria 
Patients belonging to ASA grade I and grade II  
Exclusion criteria 
• Local sepsis 
• Glaucoma 
• Serious impairment of coagulation 
• Orbital abnormalities 
• Patients refusal  
• Un-cooperative patients 
•  Patients unable to lie supine for long. 
Study groups – Group R and Group B 
Group R  coded syringe contains 8ml of 1:1 mixture of 2% 
lidocaine,  0.75% ropivacaine  and 15 IU/ml of  hyaluronidase.  
Group B   coded   syringe contains  8ml of  1:1 mixture of  2%  
lidocaine,  0. 5% bubivacaine and  15 IU/ml of  hyaluronidase. 
  
 
All patients were thoroughly examined preoperatively in the 
assessment room. Basic  parameters like pulse rate, blood pressure, 
respiratory rate and baseline investigations like hemoglobin, urine 
analysis for albumin and sugar, blood sugar, urea and creatinine and ECG 
were checked.  
In the operation room, appropriate equipments for airway 
management and emergency drugs were kept ready. 
An initial preoperative counselling and reassurance to gain 
confidence of the patients was done. Informed consent was obtained and 
procedure was explained in patient’s vernacular language. Visual analog 
scale (VAS) score was explained to all the patients. 
Patients were advised nil per oral for 6 hours before the procedure. 
All patients were premedicated with Tab. Diazepam 5 mg orally,  2  
hours before the surgery. 
Patients were shifted to the operating room on  a stretcher and  
placed on operating table in supine position. Noninvasive blood pressure, 
oxygen saturation and ECG of all the patients were monitored. 
Preoperative baseline systolic and diastolic blood pressure, pulse rate, 
respiratory rate and oxygen saturation were recorded. Patients were  
cannulated with 18G intravenous cannula in nondominant hand. One drop 
  
 
of 4% lidocaine was administered topically on the day of operation to 
measure baseline intraocular pressure with Schiotz tonometer. 
Peribulbar block was performed as per Bloomberg’s 9 modification 
of the Davis and Mandel technique.  
Patients were asked to maintain the eye in the primary gaze directly 
ahead. A 22G , 25mm needle was  inserted in the inferotemporal region 
through the skin, at the junction of medial 2/3rd and lateral 1/3rd of the 
lower orbital margin. Once the needle was under the globe, it was 
directed along the orbital floor  up  to the  depth of the mid-orbit in the 
lateral extra conal space and not in an upward and inward direction to 
avoid injury to optic nerve. After careful negative aspiration, 5 ml of local 
anesthetic was given.  
The second injection was given in the supero-nasal area by 
inserting the same needle through the upper eyelid vertically above the 
medial limbus to a depth of 2cm, aiming tangentially away from the 
globe in the medial extra conal space and 3 ml of local anesthetic was 
given.  Manual compression and gentle massage of the eyeball were 
performed to facilitate spread of anaesthetic solution.  
  
 
  Patients were assessed for sensory block, eyelid and ocular 
movements at 2 minutes  intervals. Systolic, diastolic and mean arterial 
pressures, heart rate & oxygen saturation were monitored non invasively 
at 1,3,5,8,10,15 and then every 10 minutes till the end of the surgery. 
Sensory block  
Sensory block was evaluated by loss of sensation of the cornea 
with cotton. This assessment was started 2,4,6,8 &10 minutes after 
injection. Onset of sensory block was taken as the time from injection to 
loss of  corneal sensation.  
Motor block. 
Ocular globe motility was evaluated in the four quadrants using a       
3-point scoring system: 
 0   -  Akinesia (ocular movement <1 mm), 
 1   -  Reduced movement (ocular movement >1 mm but < 4 mm), 
 2   - Normal movement (ocular movement >4 mm). 
This scoring system gives  a maximal aggregate score of 8 for the 
four muscles. A score of ≤ 2, reduced movements in all directions, was 
taken to indicate successful block. Once successful block had been 
achieved, no further assessments were made. 
  
 
Quality of surgical anaesthesia: 
Surgical anaesthesia was graded as 
• Excellent -  No pain at any time during  surgery. 
• Good      -  Minimal  pain or discomfort. 
• Poor      - Failed block leading to conversion to general anaesthesia. 
Intraoperatively, oxygen 4 litres/min was administered  via the 
nasal cannula to all the patients under sterile drapes. 
Assessment of pain 
Patients were shifted to post anaesthesia care unit after completion 
of surgery. Vital signs were recorded every 15 minutes in the first hour 
after surgery, every 30 minutes for the next 2 hours and thereafter,  every 
hour for the next 3 hours.  
Pain assessment using VAS  was done every 15 minutes till VAS 
score ≥ 3 was reached .  Once  this  score  was  reached,  patients  were  
given Tab. Ibuprofen 400mg and Tab. Paracetamol 500mg  orally as 
rescue analgesia. 
Duration of effective analgesia was defined as time interval 
between peribulbar block and the time to reach VAS Score ≥ 3.   
Resolution of motor blockade could not be assessed, as patient’s 
eyes were bandaged  and covered after the operation.  
  
 
 
OBSERVATION  AND RESULTS 
Methods 
The data collected were subjected to statistical analysis. 
Continuous variables are presented as mean ± SD,  ordinal and nominal 
data are presented as number and percentage. Comparison between these 
groups were made using Student’s t test for quantitative data and                    
Pearson’s chi square (X 2 )test for qualitative data. 
The Patients characteristics such as Age, Height, and Weight were 
analyzed by using Student’s t test. The sex of the patient was analyzed by 
using contingency table analysis with Pearson’s  chi square  (X 2 ) test.  
Onset of sensory block, onset of motor block (minutes) and 
duration of analgesia among Group(B) and Group(R)  were analyzed  
using Student's  t tests. P value of <0.05 was considered as significant.  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Demographic characteristics of the study subjects 
Sex distribution. 
            2% Lidocaine  and  0.5% Bupivacaine – Group - B 
 
Sex Frequency Percent 
Female 13 43.3 
Male 17 56.7 
 
            2% Lidocaine and  0.75% Ropivacaine – Group – R  
Sex Frequency Percent 
Female 19 63.3 
Male 11 36.7 
 
 
  
 
 
 
     
       
 Patients Characteristics 
Patient Characteristics GROUP - B GROUP - R P value  
Age (years)* 55.57 + 5.75 56.23 + 5.61 0.651 
Sex  (Male/Female) 17/13 11/19 0.196 
Weight*(kgs) 59.03 + 3.60 57.46 + 4.30 0.131 
 
* values are expressed as mean + S.D 
 
There was no significant difference between both the study 
groups with regard to age, sex and weight. Patient’s characteristics were 
similar and comparable between the two study groups.  
 
 
 
  
 
  
 
 
ONSET OF SENSORY BLOCKADE ( in minutes) 
 
Time (in 
minutes) 
GROUP - B GROUP - R 
Frequency Percent Frequency Percent 
0-2 11 36.7 12 40.0 
3-4 18 60.0 18 60.0 
5-6 1 3.3 0 0.0 
 
Since the p value was >0.05, there was no significant difference in 
the onset of sensory block between the study groups.   
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
ONSET OF MOTOR BLOCKADE (in minutes) 
 
Time (in 
minutes) 
GROUP- B GROUP - R 
Frequency Percent Frequency Percent 
3-4 2 6.7 1 3.3 
5-6 18 60.0 6 20.0 
7-8 6 20.0 20 66.7 
9-10 4 13.3 3 10.0 
 
 
Since the p value was <0.05, there was a statistically significant 
difference in the onset of motor blockade  among group B and group R, 
showing bupivacaine has a rapid onset of motor blockade when compared 
with ropivacaine. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
DURATION OF ANALGESIA  (in Minutes) 
 
Time (in 
minutes) 
GROUP - B GROUP - R 
Frequency Percent Frequency Percent 
121-240 7 23.3 2 6.7 
241-360 21 70.0 9 30.0 
361-480 2 6.7 14 46.6 
481-600 0 0.0 5 16.7 
 
Since the p value was <0.05 , there was a  statistically significant 
difference in the duration of analgesia among group B and group R, 
showing ropivacaine has a longer duration of analgesia  when compared 
with bupivacaine. 
 
 
 
 
 
  
 
DESCRIPTION GROUP - B GROUP - R P value 
ONSET OF SENSORY 
BLOCK ( in minutes) 
2.70 + .65 2.63 + .57 
0.671 
 
ONSET OF MOTOR 
BLOCK  ( in minutes) 
6.53 + 1.81 7.57 + 1.46 
0.018 
 
DURATION OF 
ANALGESIA  (in 
minutes) 
295.00 + 54.63 414.67 + 99.47 
0.001 
 
 
From the statistical analysis there was no statistically significant 
difference between the two study groups with regard to age, sex and 
weight. 
Mean time [SD] for the onset of sensory blockade was 2.70 ± 
6.5minutes in Group B and 2.63 ± 0.57minutes in group R. Since the p 
value was 0.671, there was no significant difference in the onset of 
sensory blockade between both groups.    
  
 
 
Mean time [SD] for the onset of motor blockade was 6.53 ± 1.81 
minutes in group B, and 7.57 ± 1.46 minutes in the group R.  
Mean time [SD] for the duration of analgesia lasted for 295 ± 54.63 
minutes in group B and 414.67 ± 99.47 in group R. The p value for the 
onset of motor blockade  and duration of analgesia were 0.018 and 0.001 
respectively. Since the p value was <0.05, there was a statistically 
significant difference among both the groups, with regard to onset of 
motor blockade  and duration of analgesia. 
 
 
 
 
 
 
 
 
 
 
  
 
 
DISCUSSION 
 
The use of regional anesthesia for ophthalmic surgery is  popular 
because it is associated with fewer respiratory and hemodynamic 
untoward events when compared to  general anesthesia. Moreover, 
postoperative pain relief and the incidence of nausea and vomiting are 
less with  regional anesthesia  
The use of retrobulbar anesthesia is associated with rare, but severe 
complications such as ocular perforation, direct optic nerve injury, 
extraocular muscle paresis, severe retrobulbar hemorrhage, retinal 
vascular occlusion, contralateral amaurosis, and systemic local anesthetic 
toxicity. To reduce the morbidity associated with retrobulbar anesthesia, 
Davis and Mandel  developed  peribulbar block, which seems to be 
associated with fewer complications than retrobulbar anesthesia . For this 
reason, peribulbar anesthesia is now considered a safe and effective 
technique for cataract surgery.  
Bupivacaine alone might seem more appropriate as a control drug 
than the lidocaine-bupivacaine mixture; however  the protocol of the 
Ophthalmology department of our institution is to use  lidocaine-
  
 
bupivacaine mixture for peribulbar block, combining lidocaine’s faster 
onset time and  bupivacaine’s  longer postoperative pain relief.  
This study was done in our institution, where we use a mixture of 
lidocaine,  bupivacaine  and  hyaluronidase. The aim of our present study 
is to find out the usefulness of  ropivacaine, a newer local anaesthetic, 
which  is considered to have a longer duration of action and lesser 
toxicity.         
   On  statistical analysis of the data obtained from the group of 60 
patients with similar demographic profile, we found that there was no 
statistically significant difference between the group R and group B with 
regard to onset of sensory blockade.  This corresponds to study done by 
Huha T et al27, who concluded that there were no clinically significant 
differences in the sensory blockade between 1% ropivacaine and 0.75% 
bupivacaine in peribulbar anaesthesia for cataract surgery.  
Regarding the onset of motor blockade, Group B had a statistically 
significant rapid onset of motor blockade when compared to Group R. 
This corresponds to study done by  Perello A et al28, who concluded that 
there was a slower onset of akinesia in using ropivacaine alone. This 
could have been due to better motor blockade produced by 0.5% 
bupivacaine when compared to 0.75%  ropivacaine, which produces more 
  
 
of sensory blockade.  But the limitation in our study regarding the onset 
of motor blockade is the addition of 2% lidocaine to the local anaesthetic 
mixture, which is the protocol of our ophthalmology department.  
         Regarding the duration of analgesia, our study showed highly 
statistically significant prolongation of duration of analgesia with  
group R, which corresponds to the study done by Luigi Gioia et al26, who  
compared 0.75% ropivacaine with a mixture of 2% lidocaine and  
0.5% bupivacaine, and demonstrated that ropivacaine has an onset similar 
to that of the lidocaine-bupivacaine mixture and provides a prolonged 
duration of postoperative analgesia.  
    From  our study we found that the total duration of sensory 
blockade, which the patients  benefits  as  an effective postoperative 
analgesia, is statistically significant,   proving   the efficacy  of  
0.75%  ropivacaine, a newer local anaesthetic  in peribulbar block. 
 
 
 
  
 
 
 
 
 
 
CONCLUSION 
 
We  conclude from our study that  Inj. 0.75% Ropivacaine given 
for peribulbar block is a better and safer choice of  local anaesthetic to 
prolong the postoperative pain relief when compared to  
Inj. 0.5%  Bupivacaine. 
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PROFORMA 
 
COMPARISION OF 1:1 MIXTURE OF 2% LIDOCAINE AND 
0.5% BUPIVACAINE  WITH 2% LIDOCAINE AND 0.75% 
ROPIVACAINE 
 
 
 
NAME :        IP   NO: 
 
AGE / SEX : 
 
WEIGHT: 
 
          
      
 
DIAGNOSIS:       SURGERY: 
 
 
 
PREOP ASSESSMENT: 
 
PULSE RATE :     CVS: 
  
BLOOD PRESSUE:     RS: 
 
TEMP :      CNS: 
 
SPO2:       ABD: 
 
AIRWAY: 
 
TEETH:   MPC:    I /II / III /IV   TMD: 
 
     MOUTH OPENING 
 
ASA GRADING : I / II 
 
INVESTIGATION: 
 
    
Hb% PCV BT CT ECG CXR RFT 
       
 
 PREMEDICATION:   Tab. Diazepam 5mg  orally 2 hours before surgery. 
  
 
 
 
MONITORING: NIBP , HR , ECG , SPO2. 
 
 
GROUP  R  :  1:1 MIXTURE OF 2% LIDOCAINE AND   
0.75%  ROPIVACAINE. 
 
GROUP  B :  1:1 MIXTURE OF 2% LIDOCAINE AND   
0.5%  BUPIVACAINE. 
 
 
ONSET  OF  THE   SENSORY  BLOCKADE  [IN  MINUTES]: 
 
 
ONSET  OF  THE   MOTOR   BLOCKADE  [IN  MINUTES]: 
  
3 POINT SCORING SYSTEM. 
 
OCULAR  GLOBE  MOTILITY 
  
0 -  AKINESIA 
 
1 – REDUCED MOVEMENT 
 
2 – NORMAL MOVEMENT 
 
 
QUALITIY OF BLOCK FOR SURGERY AFTER 10 MINUTES 
 
 SATISFACTORY BLOCK 
 
 UNSATISFACTORY BLOCK 
 
 COMPLETE FAILURE 
 
 
DURATION OF SENSORY BLOCKADE [IN  MINUTES]: 
 
OBSERVATION 
 
  
 
 
 
 
  
 
INTRA OPERATIVE PERIOD   
 
 
Time (min) 1 3 5 8 10 15 20 25 30 35 40 50 60 75 90 105 120 
Onset  of 
the Sensory 
blockade 
                 
Onset of  
Motor 
blockade 
                 
Quality of 
blockade 
                 
H R                  
SpO2                  
B P                  
ECG                  
VAS                  
 
 
POST OPERATIVE PERIOD  12 HOURS 
 
  
Time (min) 150 180 210 240 270 300 360 420 480 540 600 660 720 
Complaints 
of pain 
             
HR              
SPO2              
BP              
ECG              
VAS              
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
